The US Food and Drug Administration’s Division of Seafood Safety is announcing the availability of specific chapters and appendixes of the “Fish and Fishery Products Hazards and Controls Guidance, Fourth Edition” now dated August 2019.
The FDA recently held a hearing designed to include information and views related to the safety of cannabis edibles and beverages—with a strong emphasis on cannabidiol (CBD) ingredients—as well as to solicit input relevant to the agency's regulatory strategy for existing products.
The U.S. Food and Drug Administration has announced issuance of the first warning letter using the authority under the FDA Food Safety Modernization Act (FSMA) Final Rule on Foreign Supplier Verification Programs (FSVP) for Importers of Food for Humans and Animals
The U.S. Food and Drug Administration is amending the color additive regulations to provide for the safe use of soy leghemoglobin as a color additive in uncooked ground beef analogue products (e.g., vegetable burgers).
The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention and state and local partners investigated a multistate outbreak of foodborne illnesses associated with the consumption of raw oysters harvested in Estero El Cardon, Baja California Sur, Mexico between the dates of February 12, 2019 and April 9, 2019.
The FDA held a public hearing on May 31 to solicit oral presentations and comments in order to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived products.
Unless your facility is a USDA shop, then it most likely falls under FSMA regulations, which for the vast majority of processors is the law of the land. If you haven’t yet been visited by FDA for an audit, it is past time to get ready for that inevitable moment. I asked Ib Elandaloussi (CAL), Food and Consumer Products Group with Burns and McDonnell to talk briefly about designing facility solutions to meet FSMA rules.
USDA's FSIS and FDA released a formal agreement to address the regulatory oversight of human food products derived from the cells of livestock and poultry, which describes the oversight roles and responsibilities for both agencies and how they will collaborate to regulate the development and entry of these products into commerce.